Showing results (51-60 of 102) with videos related to
Sort By:
Pageof 11
Clinical Hematology International|February 22, 2023
The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic LeukemiaSevastianos Chatzidavid, Christina-Nefeli Kontandreopoulou, Panagiotis T Diamantopoulos, et al.Leukemia & Lymphoma|June 12, 2019
Safety and efficacy analysis of long-term follow up real-world data with ibrutinib monotherapy in 58 patients with CLL treated in a single-center in GreeceMaria Dimou, Theodoros Iliakis, Vasileios Pardalis, et al.Experimental Hematology & Oncology|December 6, 2012
Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myelomaEfstathios Koulieris, Panayiotis Panayiotidis, Stephen J Harding, et al.Plant Physiology|April 13, 2004
Characterization of three functional high-affinity ammonium transporters in Lotus japonicus with differential transcriptional regulation and spatial expressionEnrica D'Apuzzo, Alessandra Rogato, Ulrike Simon-Rosin, et al.British Journal of Haematology|June 22, 2006
Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significanceGeorgios Georgiou, Vasiliki Karali, Christina Zouvelou, et al.Medicina (Kaunas, Lithuania)|October 27, 2022
Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory BiomarkersAlexia Piperidou, Eleftherios Zografos, Theodoros J Vassilakopoulos, et al.Leukemia & Lymphoma|February 24, 2026
Deciphering the role of HMGA2 and let-7 microRNAs in myelodysplastic neoplasms with bone marrow fibrosisDimitra Vlachopoulou, Christina-Nefeli Kontandreopoulou, Panagiotis T Diamantopoulos, et al.Hematology Reports|May 27, 2026
Novel Approaches to the Management of Myelodysplastic Syndromes: The Roles of Artificial Intelligence and Oxidative Stress BiomarkersIoannis Tsamesidis, Georgios Drillis, Sotirios Varlamis, et al.Hemasphere|January 25, 2020
Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective StudyKonstantinos Anargyrou, Despina Fotiou, Theodoros P Vassilakopoulos, et al.Leukemia & Lymphoma|October 8, 2024
MicroRΝΑ analysis in patients with myelodysplastic neoplasms. Possible implications in risk stratificationStavroula Syriopoulou, Christina-Nefeli Kontandreopoulou, Panagiotis T Diamantopoulos, et al.Pageof 11